A detailed history of Lebenthal Global Advisors, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 44,485 shares of BHC stock, worth $324,295. This represents 0.11% of its overall portfolio holdings.

Number of Shares
44,485
Previous 57,857 23.11%
Holding current value
$324,295
Previous $464,000 1.51%
% of portfolio
0.11%
Previous 0.11%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$7.77 - $10.61 $103,900 - $141,876
-13,372 Reduced 23.11%
44,485 $471,000
Q4 2023

Feb 07, 2024

BUY
$6.53 - $8.23 $56,373 - $71,049
8,633 Added 17.54%
57,857 $464,000
Q3 2023

Nov 08, 2023

SELL
$7.69 - $9.71 $86,128 - $108,752
-11,200 Reduced 18.54%
49,224 $404,000
Q2 2023

Aug 08, 2023

SELL
$5.72 - $8.8 $93,539 - $143,906
-16,353 Reduced 21.3%
60,424 $483,000
Q1 2023

May 05, 2023

BUY
$6.28 - $9.85 $6,236 - $9,781
993 Added 1.31%
76,777 $621,000
Q4 2022

Feb 06, 2023

BUY
$6.09 - $7.93 $196,067 - $255,306
32,195 Added 73.86%
75,784 $475,000
Q3 2022

Nov 08, 2022

BUY
$4.58 - $9.21 $256 - $515
56 Added 0.13%
43,589 $300,000
Q2 2022

Aug 05, 2022

BUY
$7.06 - $23.63 $61,026 - $204,257
8,644 Added 24.78%
43,533 $363,000
Q1 2022

May 10, 2022

BUY
$21.6 - $27.79 $198,180 - $254,973
9,175 Added 35.68%
34,889 $797,000
Q4 2021

Apr 15, 2022

BUY
$23.0 - $29.01 $2,576 - $3,249
112 Added 0.44%
25,714 $709,000
Q4 2021

Feb 15, 2022

BUY
$23.0 - $29.01 $30,912 - $38,989
1,344 Added 5.54%
25,602 $706,000
Q3 2021

Nov 01, 2021

BUY
$25.04 - $30.06 $1,076 - $1,292
43 Added 0.18%
24,258 $675,000
Q2 2021

Aug 05, 2021

BUY
$27.43 - $32.7 $182,272 - $217,291
6,645 Added 37.82%
24,215 $710,000
Q1 2021

May 07, 2021

SELL
$21.37 - $34.38 $134,737 - $216,765
-6,305 Reduced 26.41%
17,570 $557,000
Q4 2020

Feb 12, 2021

BUY
$15.31 - $21.12 $365,526 - $504,240
23,875 New
23,875 $494,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.64B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Lebenthal Global Advisors, LLC Portfolio

Follow Lebenthal Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.